Quetiapine Fumarate in pharma franchise in Odisha

Quetiapine Fumarate in PCD pharma franchise in Karnataka

Quetiapine Fumarate in top pharma company in Thane

Quetiapine Fumarate in pcd pharma supplier in Patna

Quetiapine Fumarate in phama franchise company in India
Quetiapine Fumarate in phama distributor in Ludhiana

Home/Products /quetiapine-fumarate-i-point-p-point-50mg-tablets

Qtpair 50 Tablet

Composition : Quetiapine Fumarate I.P. 50mg Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹89/-

Qtpair 50 Tablet contains Quetiapine Fumarate, a second-generation antipsychotic, used for treating schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder. Quetiapine works by affecting the balance of neurotransmitters in the brain, specifically serotonin and dopamine, thereby improving mood, reducing anxiety, and preventing psychotic episodes.

This medication is available in 50mg dosage, suitable for patients requiring a moderate dose of Quetiapine. It may also be prescribed to control symptoms of mania in bipolar disorder or to prevent mood swings associated with it. Additionally, it has demonstrated efficacy in treating major depressive disorder as part of combination therapy when other treatments do not provide sufficient relief.

Read More

About the Product

Qtpair 50 Tablet contains Quetiapine Fumarate, a second-generation antipsychotic, used for treating schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder. Quetiapine works by affecting the balance of neurotransmitters in the brain, specifically serotonin and dopamine, thereby improving mood, reducing anxiety, and preventing psychotic episodes.

This medication is available in 50mg dosage, suitable for patients requiring a moderate dose of Quetiapine. It may also be prescribed to control symptoms of mania in bipolar disorder or to prevent mood swings associated with it. Additionally, it has demonstrated efficacy in treating major depressive disorder as part of combination therapy when other treatments do not provide sufficient relief.

Common side effects include drowsiness, dizziness, dry mouth, weight gain, and increased cholesterol. Rare side effects may include movement disorders, low blood pressure, and elevated blood sugar.

Treatment of schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder.

Consult your doctor before stopping or adjusting the dosage, particularly for those with pre-existing heart conditions or the elderly.

Store in a cool, dry place away from heat and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation